You are here

  • Home
  • Archive
  • Volume 11, Issue 12
  • Tumor cell-intrinsic SETD2 inactivation sensitizes cancer cells to immune checkpoint blockade through the NR2F1-STAT1 pathway

Article metrics

Article menu
Basic tumor immunology
Original research
Tumor cell-intrinsic SETD2 inactivation sensitizes cancer cells to immune checkpoint blockade through the NR2F1-STAT1 pathway

 

Online download statistics by month:

Online download statistics by month: December 2023 to March 2026

AbstractFullPdf
Dec 2023651655338
Jan 2024291292139
Feb 202416416584
Mar 2024197198131
Apr 202417517689
May 202416116586
Jun 202412312971
Jul 2024140144125
Aug 202413313365
Sep 202413213678
Oct 202415315376
Nov 202415015177
Dec 202420020794
Jan 202512212257
Feb 202532432583
Mar 2025147149105
Apr 2025163166103
May 202518418591
Jun 2025929466
Jul 2025110
Mar 2026110
Total370437471958